50 Participants Needed

Communication Intervention for Cancer Planning

Recruiting at 2 trial locations
MS
CD
Megan J. Shen, PhD - Associate ...
Overseen ByMegan J Shen, PhD.
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Weill Medical College of Cornell University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This trial tests whether Planning for Your Advance Care Needs (PLAN) intervention works to enhance Latino patients' understanding of and engagement in advanced care planning. The PLAN intervention may be an effective method to help people with cancer plan for and talk about advance care planning (the care they would want if they were unable to communicate) with their loved ones and doctors.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Planning for Your Advance Care Needs (PLAN) for cancer patients?

Research shows that advance care planning, which involves discussing and recording patient preferences for future care, can improve communication between patients and doctors, especially at the end of life. Educating people about advance care planning has been effective in encouraging them to start important conversations and make necessary preparations.12345

Is the Communication Intervention for Cancer Planning safe for humans?

The research articles reviewed do not provide specific safety data for the Communication Intervention for Cancer Planning or its related programs.678910

How is the treatment 'Planning for Your Advance Care Needs' different from other treatments for cancer planning?

This treatment is unique because it focuses on improving communication skills for advance care planning, helping patients and their families have important conversations about future healthcare decisions, rather than focusing on medical or pharmaceutical interventions.58111213

Research Team

Megan J. Shen, PhD - Associate ...

Megan J Shen, PhD.

Principal Investigator

Fred Hutch/University of Washington Cancer Consortium

Eligibility Criteria

This trial is for Latino adults with advanced or metastatic cancer who have had at least one round of chemotherapy. They must be able to give informed consent and speak English or Spanish fluently. It's not suitable for those severely cognitively impaired, too ill to interview, currently in hospice care, under 18, or deemed unsuitable by their oncologist.

Inclusion Criteria

You are of Latino ethnicity.
My cancer is advanced or has spread, and it got worse after my first chemotherapy.
Ability to provide informed consent

Exclusion Criteria

Patients deemed inappropriate for the study by their treating oncologist
I am too sick or weak to complete interviews.
I am under 18 years old.
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants in Arm I receive the PLAN intervention, consisting of 3 coaching sessions over 45-60 minutes each with a health coach. Arm II participants receive usual care.

1 week
3 visits (in-person or virtual)

Follow-up

Participants are monitored for changes in engagement, self-efficacy, completion of advance directives, feasibility, acceptability, knowledge, and readiness/motivation in advance care planning.

3 months
2 visits (in-person or virtual)

Treatment Details

Interventions

  • Planning for Your Advance Care Needs (PLAN)
Trial Overview The trial examines the 'PLAN' intervention—a method aimed at improving Latino cancer patients' understanding and participation in advance care planning discussions with family and doctors. It involves a communication strategy, adherence to best practices, and questionnaire feedback.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Arm I (PLAN intervention)Experimental Treatment2 Interventions
Patients participate in PLAN intervention, consisting of 3 coaching sessions over 45-60 minutes each with a health coach.
Group II: Arm II (Best practice)Active Control2 Interventions
Patients receive usual care.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Weill Medical College of Cornell University

Lead Sponsor

Trials
1,103
Recruited
1,157,000+

Fred Hutchinson Cancer Center

Lead Sponsor

Trials
583
Recruited
1,341,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Findings from Research

In a study involving 59 patients with metastatic urological cancers, 85% successfully completed an advance directive or POLST form, indicating a high rate of advance care planning when integrated palliative care is offered immediately after urology appointments.
The majority of patients (98%) expressed a preference to withhold aggressive end-of-life interventions, such as cardiopulmonary resuscitation and artificial nutrition, highlighting a general aversion to aggressive treatments in terminal illness situations.
Advance Care Planning and Patient Preferences in a Feasibility Pilot Study to Improve End-of-Life Communication among Men with Metastatic Urological Malignancies.Pannell, SC., Laviana, AA., Huen, KHY., et al.[2023]
Advance care planning can significantly improve end-of-life care by decreasing the use of life-sustaining treatments and increasing the use of hospice and palliative care, based on a systematic review of 113 studies published between 2000 and 2012.
Complex interventions in advance care planning are more effective in ensuring that patients' end-of-life wishes are met compared to simpler methods like written directives, highlighting the need for more experimental studies in diverse settings.
The effects of advance care planning on end-of-life care: a systematic review.Brinkman-Stoppelenburg, A., Rietjens, JA., van der Heide, A.[2022]
In a study of 456 patients with terminal cancer, only 6% had documented care goals in case of acute deterioration, highlighting a significant gap in advance care planning.
A quality improvement initiative was launched to enhance documentation and referral rates to palliative care, aiming to ensure better patient support and care planning in the future.
Toward improved goals-of-care documentation in advanced cancer: report on the development of a quality improvement initiative.Harle, I., Karim, S., Raskin, W., et al.[2022]

References

Advance Care Planning and Patient Preferences in a Feasibility Pilot Study to Improve End-of-Life Communication among Men with Metastatic Urological Malignancies. [2023]
The effects of advance care planning on end-of-life care: a systematic review. [2022]
Toward improved goals-of-care documentation in advanced cancer: report on the development of a quality improvement initiative. [2022]
Resident approaches to advance care planning on the day of hospital admission. [2006]
Impact of a community health conversation upon advance care planning attitudes and preparation intentions. [2021]
The PREPARE for Your Care program increases advance care planning engagement among diverse older adults with cancer. [2022]
Why is advance care planning underused in oncology settings? A systematic overview of reviews to identify the benefits, barriers, enablers, and interventions to improve uptake. [2023]
Development of a Community Advance Care Planning Guides Program and the RELATE Model of Communication. [2022]
Definition and recommendations for advance care planning: an international consensus supported by the European Association for Palliative Care. [2018]
10.United Statespubmed.ncbi.nlm.nih.gov
Development of an advance directive 'communication tool' relevant for patients with advanced cancer in six European countries: Experiences from the ACTION trial. [2022]
Impacts of an advance care planning intervention on close relationships. [2023]
Development and feasibility of a communication training to assist caregivers with advanced care planning. [2023]
Advance Care Planning and Goals of Care Discussion: Barriers from the Perspective of Medical Residents. [2023]